Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 5Thoracic 1Head & Neck 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 169Head and Neck Neoplasms 151Carcinoma, Squamous Cell 33Neoplasm Metastasis 18Laryngeal Neoplasms 17Colorectal Neoplasms 17Tongue Neoplasms 16Neoplasms 16Mouth Neoplasms 16Recurrence 14Oropharyngeal Neoplasms 14Carcinoma, Non-Small-Cell Lung 14Salivary Gland Neoplasms 12Hypopharyngeal Neoplasms 11Carcinoma 11Laryngeal Diseases 10Breast Neoplasms 10Nasopharyngeal Carcinoma 9Pancreatic Neoplasms 6Neoplasms, Squamous Cell 6Sarcoma 5Pharyngeal Neoplasms 5Parkinson Disease 4, Autosomal Dominant Lewy Body 5Colonic Neoplasms 5Carcinoma, Renal Cell 5Stomach Neoplasms 4Rectal Neoplasms 4Ovarian Neoplasms 4Melanoma 4Lymphoid Interstitial Pneumonia 4

Interventions

Fulvestrant 2Alpelisib 2tipifarnib 1ribociclib 1palbociclib 1exemestane 1abemaciclib 1Tamoxifen 1STX-478 1SF 1126 1Panobinostat 1PX-866 1Metformin 1Letrozole 1Imlunestrant 1Everolimus 1Docetaxel 1Cetuximab 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hereditary Sensory and Autonomic Neuropathies × Cetuximab × Head & Neck × Clear all
NCT01602315 2020-12-29

A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

Novartis

Phase 1/2 Terminated
179 enrolled 38 charts
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Hereditary Sensory and Autonomic Neuropathies

Data powered by HemOnc (CC BY 4.0) Colophon âš¡